Search

Search Constraints

You searched for: Author/Creator Serruys, Patrick W

Search Results

1. 'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trial. Issue 7 (2nd July 2021)

2. 1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis. Issue 10025 (26th March 2016)

3. 2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy. Issue 10096 (19th August 2017)

4. 68 Predicting 3-Year Mortality After PCI: Revised Clinical Syntax Model Based on Patient Level Data from 7 Contemporary Stent Trials. (31st May 2014)

5. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial. Issue 9962 (3rd January 2015)

6. A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial. Issue 10119 (3rd February 2018)

7. Angiographic derived endothelial shear stress: a new predictor of atherosclerotic disease progression. (17th July 2018)

8. Angiographic late lumen loss revisited: impact on long-term target lesion revascularization. (16th August 2018)

9. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. Issue 10317 (11th December 2021)

10. Aspirin-free antiplatelet regimens after PCI: insights from the GLOBAL LEADERS trial and beyond. Issue 6 (30th April 2021)